Northwest Biotherapeutics, Inc. (BST:NBYB)
0.2100
-0.0180 (-7.89%)
At close: Oct 16, 2025
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of €298.11 million as of October 17, 2025. Its market cap has decreased by -18.92% in one year.
Market Cap
298.11M
Enterprise Value
366.05M
Revenue
931.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.21
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 11.37M to 298.11M, an increase of 2,520.80%. That is a compound annual growth rate of 14.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 298.11M | -15.20% |
Dec 31, 2024 | 351.54M | -52.72% |
Dec 29, 2023 | 743.52M | -4.28% |
Dec 30, 2022 | 776.73M | 33.17% |
Dec 31, 2021 | 583.27M | -43.13% |
Dec 31, 2020 | 1.03B | 790.70% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 272.75B |
Siemens Aktiengesellschaft | 186.50B |
Deutsche Telekom AG | 140.15B |
Allianz SE | 139.24B |
Siemens Energy AG | 90.23B |
Rheinmetall AG | 80.06B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 72.65B |
Deutsche Bank Aktiengesellschaft | 57.45B |